4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001209191-19-021014
Director sold 14,245 shares at $17.86 ($254,416)
- Director disposed of 726,500 shares (other)
- Director acquired 14,245 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Bruce Director | 2019-03-20 | Other disposition | −726,500 | 4,117,125 | I | ||
| Booth Bruce Director | 2019-03-20 | Other acquisition | +14,245 | 14,245 | I | ||
| Booth Bruce Director | 2019-03-20 | Sale | −14,245 | $17.86 | $254,416 | 0 | I |
| Open-market sales · 14,245 sh · avg $17.86 · $254,416 | |||||||
Loading xslF345X03/doc4.xml…